TapewireFind a company

person · Reporting owner

Wu Xiaobin

Disclosed activity across 1 company

Tapewire entity
18998
SEC CIK
0001739452

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
BeOne Medicines Ltd.ONC · Entity 2168President and COOAugust 25, 2026August 27, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

BeOne Medicines Ltd.

Report date August 25, 2026 · Filed August 27, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
American Depositary SharesSEC Table I · non-derivativeDirect0 Reported balance After 2026-08-25 transaction · row 4 Holding and transaction disclosures are not merged.
1 source row

Row 4 · 2026-08-25 · Sale · Disposed 280 · Balance 0

F1: Each American Depositary Share represents 13 Ordinary Shares.

F2: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025.

American Depositary SharesSEC Table I · non-derivativeDirect12,365 Reported balance Holding disclosure · report date 2026-08-25 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 12,365

F1: Each American Depositary Share represents 13 Ordinary Shares.

Ordinary SharesSEC Table I · non-derivativeDirect1,270,084 Reported balance Holding disclosure · report date 2026-08-25 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 1,270,084

American Depositary SharesSEC Table I · non-derivativeIndirectBy Wife4,000 Reported balance Holding disclosure · report date 2026-08-25 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 4,000

F1: Each American Depositary Share represents 13 Ordinary Shares.

Filing footnotes · ownership attribution and instrument terms

F1: Each American Depositary Share represents 13 Ordinary Shares.

F2: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 25, 2026 Filed Aug 27, 2026 21:12 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 280 $380.00 $106,400.00
Disclosure

SEC source: 0001739452-26-000011 · wk-form4_1787865149.xml · nonDerivative · entry 4

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025.

Read SEC document
June 23, 2026 Filed Jun 25, 2026 21:15 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 1,292 $276.26 $356,926.89
Disclosure

SEC source: 0001739452-26-000008 · wk-form4_1782422104.xml · nonDerivative · entry 4

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $276.23 to $276.475, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 21:19 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 1,357 $266.76 $361,996.85
Disclosure

SEC source: 0001739452-26-000007 · wk-form4_1781817585.xml · nonDerivative · entry 4

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.4658 to $266.8575, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
June 11, 2026 Filed Jun 15, 2026 21:55 UTC BeOne Medicines Ltd. ONC · Entity 2168 GrantShare Option (Right to Buy) · Derivative 229,775 $0.00 Strike: $20.81 $0.00
Disclosure

SEC source: 0001739452-26-000006 · wk-form4_1781560516.xml · derivative · entry 5

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 229,775

Underlying: Ordinary Shares · 229,775 shares

Expires 2036-06-10

F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.

F5 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.

F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 11, 2026 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
June 11, 2026 Filed Jun 15, 2026 21:55 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 626 $261.20 $163,512.26
Disclosure

SEC source: 0001739452-26-000006 · wk-form4_1781560516.xml · nonDerivative · entry 4

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.19 to $261.29, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
June 11, 2026 Filed Jun 15, 2026 21:55 UTC BeOne Medicines Ltd. ONC · Entity 2168 GrantOrdinary Shares 118,625 $0.00 $0.00
Disclosure

SEC source: 0001739452-26-000006 · wk-form4_1781560516.xml · nonDerivative · entry 1

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,308,161

F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 11, 2026, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
June 08, 2026 Filed Jun 10, 2026 21:23 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 40 $270.55 $10,822.00
Disclosure

SEC source: 0001739452-26-000005 · wk-form4_1781126634.xml · nonDerivative · entry 5

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

Read SEC document
June 08, 2026 Filed Jun 10, 2026 21:23 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 1,444 $269.33 $388,916.13
Disclosure

SEC source: 0001739452-26-000005 · wk-form4_1781126634.xml · nonDerivative · entry 4

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $268.88 to $269.75, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
March 06, 2026 Filed Mar 11, 2026 00:12 UTC BeOne Medicines Ltd. ONC · Entity 2168 GrantOrdinary Shares 78,624 $0.00 $0.00
Disclosure

SEC source: 0001739452-26-000002 · wk-form4_1773187917.xml · nonDerivative · entry 2

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,216,524

F2 · shares: Represents the total number of ordinary shares underlying the performance share units earned by Reporting Person. The earned performance share units will vest in 2028, subject to the Reporting Person continuing to provide service to the Company through such vesting date. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
March 06, 2026 Filed Mar 11, 2026 00:12 UTC BeOne Medicines Ltd. ONC · Entity 2168 GrantOrdinary Shares 168,922 $0.00 $0.00
Disclosure

SEC source: 0001739452-26-000002 · wk-form4_1773187917.xml · nonDerivative · entry 1

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,137,900

F1 · shares: Represents the total number of ordinary shares underlying the performance share units earned by Reporting Person. The earned performance share units will vest in 2027, subject to the Reporting Person continuing to provide service to the Company through such vesting date. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
November 17, 2025 Filed Nov 19, 2025 21:57 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 10 $382.32 $3,823.20
Disclosure

SEC source: 0001739452-25-000006 · wk-form4_1763589459.xml · nonDerivative · entry 6

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
November 17, 2025 Filed Nov 19, 2025 21:57 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 826 $381.19 $314,862.20
Disclosure

SEC source: 0001739452-25-000006 · wk-form4_1763589459.xml · nonDerivative · entry 5

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $381.115 to $381.88, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
November 17, 2025 Filed Nov 19, 2025 21:57 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 3,155 $380.23 $1,199,617.45
Disclosure

SEC source: 0001739452-25-000006 · wk-form4_1763589459.xml · nonDerivative · entry 4

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 836

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $380.00 to $380.765, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
November 13, 2025 Filed Nov 14, 2025 22:35 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 1,769 $381.05 $674,076.92
Disclosure

SEC source: 0001739452-25-000005 · wk-form4_1763159727.xml · nonDerivative · entry 13

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $381.00 to $381.50, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
November 13, 2025 Filed Nov 14, 2025 22:35 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 4,240 $380.33 $1,612,582.66
Disclosure

SEC source: 0001739452-25-000005 · wk-form4_1763159727.xml · nonDerivative · entry 12

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,769

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $380.00 to $380.75, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
November 12, 2025 Filed Nov 14, 2025 22:35 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 154 $362.07 $55,759.07
Disclosure

SEC source: 0001739452-25-000005 · wk-form4_1763159727.xml · nonDerivative · entry 11

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,009

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.00 to $362.33, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
November 12, 2025 Filed Nov 14, 2025 22:35 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 4,846 $360.10 $1,745,024.25
Disclosure

SEC source: 0001739452-25-000005 · wk-form4_1763159727.xml · nonDerivative · entry 10

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,163

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $360.00 to $360.945, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
November 12, 2025 Filed Nov 14, 2025 22:35 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 100 $357.43 $35,743.18
Disclosure

SEC source: 0001739452-25-000005 · wk-form4_1763159727.xml · nonDerivative · entry 9

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,009

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.385 to $357.70, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
November 12, 2025 Filed Nov 14, 2025 22:35 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 120 $355.00 $42,600.00
Disclosure

SEC source: 0001739452-25-000005 · wk-form4_1763159727.xml · nonDerivative · entry 8

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,109

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
November 12, 2025 Filed Nov 14, 2025 22:35 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 251 $354.20 $88,903.30
Disclosure

SEC source: 0001739452-25-000005 · wk-form4_1763159727.xml · nonDerivative · entry 7

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,229

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.59 to $354.585, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
November 12, 2025 Filed Nov 14, 2025 22:35 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 789 $352.78 $278,341.29
Disclosure

SEC source: 0001739452-25-000005 · wk-form4_1763159727.xml · nonDerivative · entry 6

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,480

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $352.28 to $353.10, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
November 12, 2025 Filed Nov 14, 2025 22:35 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 3,240 $351.41 $1,138,569.05
Disclosure

SEC source: 0001739452-25-000005 · wk-form4_1763159727.xml · nonDerivative · entry 5

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,269

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.05 to $351.52, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
November 12, 2025 Filed Nov 14, 2025 22:35 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 500 $350.44 $175,220.50
Disclosure

SEC source: 0001739452-25-000005 · wk-form4_1763159727.xml · nonDerivative · entry 4

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,509

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.93, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
August 14, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 119,340 $0.00 Strike: $12.23 $0.00
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · derivative · entry 27

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 358,046

Underlying: Ordinary Shares · 119,340 shares

Expires 2034-06-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F19 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F22 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events.

Read SEC document
August 14, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 399,828 $0.00 Strike: $11.98 $0.00
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · derivative · entry 26

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 309,881

Underlying: Ordinary Shares · 399,828 shares

Expires 2032-06-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F19 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F21 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 22, 2022, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control.

Read SEC document
August 14, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 600 $308.03 $184,819.32
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 23

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025.

F18 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $307.99 to $308.12, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
August 14, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 4,917 $307.43 $1,511,625.93
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 22

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 600

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025.

F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.95 to $307.93, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
August 14, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 12,232 $306.26 $3,746,189.44
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 21

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,517

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025.

F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.95 to $306.94, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
August 14, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 8,522 $305.48 $2,603,297.15
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 20

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,749

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025.

F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $304.95 to $305.94, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
August 14, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 500 $304.19 $152,097.45
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 19

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,271

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025.

F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $303.85 to $304.48, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
August 14, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 6,965 $303.31 $2,112,586.19
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 18

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,771

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025.

F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $302.79 to $303.68, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
August 14, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 5,800 $302.04 $1,751,856.94
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 17

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,736

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025.

F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.52 to $302.39, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
August 14, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 400 $300.86 $120,345.48
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 16

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,536

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.44 to $301.07, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
August 14, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 9,180 $159.03 $1,459,895.40
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 15

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,936

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
August 14, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 30,756 $155.68 $4,788,094.08
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 14

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,756

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 352,105 $0.00 Strike: $11.98 $0.00
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · derivative · entry 25

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 709,709

Underlying: Ordinary Shares · 352,105 shares

Expires 2032-06-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F19 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F21 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 22, 2022, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 296,049 $0.00 Strike: $13.42 $0.00
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · derivative · entry 24

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 296,049 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F19 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F20 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on June 17, 2021 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 9,617 $307.38 $2,956,061.92
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 13

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $307.20 to $307.51, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 9,637 $306.74 $2,956,093.86
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 12

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,617

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.19 to $307.18, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 528 $305.59 $161,352.26
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 11

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,254

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.17 to $306.13, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 7,359 $304.37 $2,239,886.79
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 10

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,782

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $304.00 to $304.80, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 3,517 $303.54 $1,067,564.25
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 9

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,141

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $303.00 to $303.98, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 5,800 $302.45 $1,754,193.76
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 8

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,658

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $302.00 to $302.97, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 4,500 $301.49 $1,356,702.75
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 7

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,458

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.00 to $301.98, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 8,900 $300.33 $2,672,961.92
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 6

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,958

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.00 to $300.99, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 27,085 $155.68 $4,216,592.80
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 5

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 49,858

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 20:40 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 22,773 $174.43 $3,972,294.39
Disclosure

SEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 4

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,773

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
June 23, 2025 Filed Jun 25, 2025 21:08 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 1,363 $260.00 $354,380.00
Disclosure

SEC source: 0001651308-25-000117 · wk-form4_1750885728.xml · nonDerivative · entry 4

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
June 17, 2025 Filed Jun 18, 2025 21:08 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 630 $250.87 $158,047.22
Disclosure

SEC source: 0001651308-25-000112 · wk-form4_1750280880.xml · nonDerivative · entry 6

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F4 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 16, 2021, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
June 16, 2025 Filed Jun 18, 2025 21:08 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 100 $266.22 $26,622.00
Disclosure

SEC source: 0001651308-25-000112 · wk-form4_1750280880.xml · nonDerivative · entry 5

Wu Xiaobin · CIK 0001739452 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 630

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.